AbbVie (ABBV)

NYSE Health Care Biotechnology S&P 500

$291.31

+3.07 (+1.07%)

Close of Nov 06, 2026 · end-of-day data

Source: AbbVie's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 04, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$25.64B	$28.22B	$32.75B	$33.27B	$45.80B	$56.20B	$58.05B	$54.32B	$56.33B	$61.16B
Cost of revenue	$5.83B	$7.04B	$7.72B	$7.44B	$15.39B	$17.45B	$17.41B	$20.41B	$16.90B	$18.20B
Gross profit	$19.81B	$21.17B	$25.04B	$25.83B	$30.42B	$38.75B	$40.64B	$33.90B	$39.43B	$42.96B
Research & development	$4.38B	$5.01B	$10.33B	$6.41B	$6.38B	$6.92B	$6.51B	$7.67B	$12.79B	$9.10B
Selling, general & admin	$5.88B	$6.29B	$7.40B	$6.94B	$11.30B	$12.35B	$15.26B	$12.87B	$14.75B	$14.01B
Operating income	$9.34B	$9.54B	$6.38B	$12.98B	$11.36B	$17.92B	$18.12B	$12.76B	$9.14B	$15.07B
Interest expense	$1.05B	$1.15B	$1.35B	$1.78B	$2.45B	$2.42B	$2.23B	$2.22B	$2.81B	$2.89B
Pre-tax income	$7.88B	$7.73B	$5.20B	$8.43B	$3.40B	$12.99B	$13.48B	$6.25B	$3.72B	$6.60B
Income tax	$1.93B	$2.42B	-$490.00M	$544.00M	-$1.22B	$1.44B	$1.63B	$1.38B	-$570.00M	$2.36B
Net income	$5.95B	$5.31B	$5.69B	$7.88B	$4.62B	$11.54B	$11.84B	$4.86B	$4.28B	$4.23B
EBITDA	$9.77B	$9.97B	$6.85B	$13.45B	$12.03B	$18.73B	$18.89B	$13.51B	$9.90B	$15.84B
EPS (basic)	$3.65	$3.31	$3.67	$5.30	$2.73	$6.48	$6.65	$2.73	$2.40	$2.37
EPS (diluted)	$3.63	$3.30	$3.66	$5.28	$2.72	$6.45	$6.63	$2.72	$2.39	$2.36
Diluted shares	1.63B	1.60B	1.55B	1.48B	1.67B	1.78B	1.78B	1.77B	1.77B	1.77B
Gross margin	77.3%	75.0%	76.4%	77.6%	66.4%	69.0%	70.0%	62.4%	70.0%	70.2%
Operating margin	36.4%	33.8%	19.5%	39.0%	24.8%	31.9%	31.2%	23.5%	16.2%	24.6%
Net margin	23.2%	18.8%	17.4%	23.7%	10.1%	20.5%	20.4%	9.0%	7.6%	6.9%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$5.10B	$9.30B	$7.29B	$39.92B	$8.45B	$9.75B	$9.20B	$12.81B	$5.52B	$5.23B
Short-term investments	$1.32B	$486.00M	$772.00M	$0	$30.00M	$84.00M	$28.00M	$2.00M	$31.00M	$28.00M
Receivables	$4.76B	$5.09B	$5.38B	$5.43B	$8.82B	$9.98B	$11.25B	$11.15B	$10.92B	$12.59B
Inventory	$1.44B	$1.60B	$1.60B	$1.81B	$3.31B	$3.13B	$3.58B	$4.10B	$4.18B	$4.95B
Total current assets	$16.19B	$21.22B	$16.95B	$49.52B	$24.17B	$27.93B	$28.46B	$33.00B	$25.58B	$29.06B
Goodwill	$15.42B	$15.79B	$15.66B	$15.60B	$33.12B	$32.38B	$32.16B	$32.29B	$34.96B	$35.64B
Total assets	$66.10B	$70.79B	$59.35B	$89.11B	$150.56B	$146.53B	$138.81B	$134.71B	$135.16B	$133.96B
Total current liabilities	$9.78B	$16.64B	$17.24B	$15.59B	$28.66B	$35.19B	$29.54B	$37.84B	$38.75B	$43.29B
Short-term debt	$377.00M	$400.00M	$3.70B	$0	$34.00M	$14.00M	$1.00M	$0	$0	$2.50B
Long-term debt	$36.44B	$30.95B	$35.00B	$67.23B	$84.95B	$75.96B	$63.13B	$59.24B	$66.84B	$64.50B
Total debt	$36.82B	$31.35B	$38.70B	$67.23B	$84.98B	$75.98B	$63.13B	$59.24B	$66.84B	$67.00B
Total liabilities	$61.46B	$65.69B	$67.80B	$97.29B	$137.49B	$131.12B	$121.55B	$124.35B	$131.84B	$137.23B
Shareholders' equity	$4.64B	$5.10B	-$8.45B	-$8.17B	$13.08B	$15.41B	$17.25B	$10.36B	$3.33B	-$3.27B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$7.04B	$9.96B	$13.43B	$13.32B	$17.59B	$22.78B	$24.94B	$22.84B	$18.81B	$19.03B
Capital expenditures	$479.00M	$529.00M	$638.00M	$552.00M	$798.00M	$787.00M	$695.00M	$777.00M	$974.00M	$1.21B
Free cash flow	$6.56B	$9.43B	$12.79B	$12.77B	$16.79B	$21.99B	$24.25B	$22.06B	$17.83B	$17.82B
Investing cash flow	-$6.07B	-$274.00M	-$1.01B	$596.00M	-$37.56B	-$2.34B	-$623.00M	-$2.01B	-$20.82B	-$6.64B
Financing cash flow	-$3.93B	-$5.51B	-$14.40B	$18.71B	-$11.50B	-$19.04B	-$24.80B	-$17.22B	-$5.21B	-$12.72B
Dividends paid	$3.72B	$4.11B	$5.58B	$6.37B	$7.72B	$9.26B	$10.04B	$10.54B	$11.03B	$11.66B
Share buybacks	$6.03B	$1.41B	$12.01B	$629.00M	$978.00M	$934.00M	$1.49B	$1.97B	$1.71B	$980.00M
Stock-based compensation	$353.00M	$365.00M	$421.00M	$430.00M	$753.00M	$692.00M	$671.00M	$747.00M	$911.00M	$955.00M
Depreciation & amortization	$425.00M	$425.00M	$471.00M	$464.00M	$666.00M	$803.00M	$778.00M	$752.00M	$764.00M	$762.00M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$14.30B	$12.31B	$14.46B	$14.46B	$15.10B	$13.34B	$15.42B	$15.78B	$16.62B	$15.00B	$16.99B	$17.40B
Cost of revenue	$5.70B	$4.09B	$4.20B	$4.21B	$4.40B	$4.00B	$4.35B	$5.30B	$4.55B	$4.22B	$4.29B	$4.29B
Gross profit	$8.60B	$8.22B	$10.26B	$10.25B	$10.71B	$9.34B	$11.08B	$10.47B	$12.07B	$10.78B	$12.70B	$13.12B
Research & development	$1.93B	$1.94B	$1.95B	$2.13B	$6.77B	$2.07B	$2.13B	$2.32B	$2.58B	$2.47B	$2.34B	$2.57B
Selling, general & admin	$3.19B	$3.31B	$3.38B	$4.21B	$3.85B	$3.29B	$3.25B	$3.57B	$3.90B	$3.58B	$3.63B	$4.09B
Operating income	$3.19B	$2.80B	$4.00B	$3.83B	-$1.49B	$3.73B	$4.89B	$1.90B	$4.54B	$3.99B	$6.43B	$6.27B
Interest expense	$564.00M	$660.00M	$726.00M	$720.00M	$702.00M	$700.00M	$740.00M	$739.00M	$714.00M	$717.00M	$746.00M	$802.00M
Pre-tax income	$1.21B	$1.75B	$2.15B	$2.08B	-$2.27B	$1.66B	$1.55B	$714.00M	$2.67B	$1.04B	$4.28B	$4.83B
Income tax	$388.00M	$383.00M	$773.00M	$520.00M	-$2.25B	$372.00M	$613.00M	$526.00M	$853.00M	$342.00M	$662.00M	$609.00M
Net income	$822.00M	$1.37B	$1.37B	$1.56B	-$22.00M	$1.29B	$938.00M	$186.00M	$1.82B	$695.00M	$3.61B	$4.22B
EBITDA	$3.38B	$2.98B	$4.18B	$4.02B	-$1.28B	$3.91B	$5.08B	$2.10B	$4.75B	$4.18B	$6.63B	$6.46B
EPS (basic)	$0.46	$0.77	$0.77	$0.88	$-0.02	$0.72	$0.52	$0.10	$1.02	$0.39	$2.04	$2.38
EPS (diluted)	$0.46	$0.77	$0.77	$0.88	$-0.02	$0.72	$0.52	$0.10	$1.02	$0.39	$2.03	$2.37
Diluted shares	1.00M	1.77B	1.77B	1.77B	1.00M	1.77B	1.77B	1.77B	1.00M	1.77B	1.77B	1.77B
Gross margin	60.1%	66.7%	70.9%	70.9%	70.9%	70.0%	71.8%	66.4%	72.6%	71.9%	74.7%	75.4%
Operating margin	22.3%	22.7%	27.6%	26.5%	-9.9%	28.0%	31.7%	12.1%	27.3%	26.6%	37.9%	36.0%
Net margin	5.7%	11.1%	9.5%	10.8%	-0.1%	9.6%	6.1%	1.2%	10.9%	4.6%	21.3%	24.2%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$12.81B	$18.07B	$13.13B	$7.26B	$5.52B	$5.17B	$6.47B	$5.63B	$5.23B	$9.39B	$6.57B	$10.77B
Short-term investments	$2.00M	$2.00M	$27.00M	$28.00M	$31.00M	$1.00M	$0	$42.00M	$28.00M	—	—	—
Receivables	$11.15B	$11.95B	$11.72B	$11.47B	$10.92B	$12.48B	$12.64B	$12.77B	$12.59B	$12.48B	$13.82B	$13.51B
Inventory	$4.10B	$4.25B	$4.22B	$4.45B	$4.18B	$4.53B	$4.96B	$4.94B	$4.95B	$5.05B	$5.13B	$5.30B
Total current assets	$33.00B	$38.87B	$33.82B	$27.79B	$25.58B	$27.68B	$29.26B	$28.54B	$29.06B	$33.53B	$33.67B	$37.48B
Goodwill	$32.29B	$33.43B	$33.39B	$35.30B	$34.96B	$35.28B	$35.64B	$35.63B	$35.64B	$35.57B	$35.52B	$37.80B
Total assets	$134.71B	$148.87B	$141.94B	$143.42B	$135.16B	$136.16B	$137.18B	$133.90B	$133.96B	$136.46B	$135.12B	$147.68B
Total current liabilities	$37.84B	$41.52B	$41.91B	$43.06B	$38.75B	$36.40B	$39.77B	$39.39B	$43.29B	$42.10B	$41.64B	$43.10B
Short-term debt	$0	$3.00M	$12.59B	$12.57B	$0	$1.59B	$5.56B	$3.79B	$2.50B	$0	$0	$0
Long-term debt	$59.24B	$63.80B	$58.05B	$58.51B	$66.84B	$64.53B	$62.96B	$62.97B	$64.50B	$64.53B	$62.48B	$72.23B
Total debt	$59.24B	$63.81B	$70.63B	$71.08B	$66.84B	$66.12B	$68.52B	$66.76B	$67.00B	$64.53B	$62.48B	$72.23B
Total liabilities	$124.35B	$140.87B	$135.16B	$137.39B	$131.84B	$134.75B	$137.37B	$136.54B	$137.23B	$143.12B	$141.05B	$152.26B
Shareholders' equity	$10.36B	$8.01B	$6.78B	$6.03B	$3.33B	$1.42B	-$183.00M	-$2.64B	-$3.27B	-$6.66B	-$5.93B	-$4.58B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$4.75B	$4.04B	$2.27B	$5.45B	$7.05B	$1.64B	$5.15B	$7.02B	$5.22B	$3.83B	$3.44B	$7.61B
Capital expenditures	$205.00M	$193.00M	$241.00M	$249.00M	$291.00M	$235.00M	$269.00M	$381.00M	$329.00M	$265.00M	$322.00M	$301.00M
Free cash flow	$4.55B	$3.85B	$2.03B	$5.20B	$6.76B	$1.40B	$4.88B	$6.64B	$4.89B	$3.56B	$3.11B	$7.30B
Investing cash flow	-$800.00M	-$9.59B	-$1.10B	-$8.26B	-$1.87B	-$735.00M	-$1.18B	-$3.26B	-$1.46B	-$574.00M	-$1.20B	-$10.21B
Financing cash flow	-$4.45B	$10.82B	-$6.10B	-$3.07B	-$6.86B	-$1.26B	-$2.71B	-$4.59B	-$4.17B	$919.00M	-$5.05B	$6.82B
Dividends paid	$2.63B	$2.77B	$2.75B	$2.75B	$2.75B	$2.92B	$2.91B	$2.91B	$2.91B	$3.09B	$3.07B	$3.07B
Share buybacks	$3.00M	$1.32B	$9.00M	$17.00M	$358.00M	$961.00M	$12.00M	$4.00M	$3.00M	$1.49B	$9.00M	$5.00M
Stock-based compensation	$125.00M	$348.00M	$218.00M	$181.00M	$164.00M	$410.00M	$179.00M	$209.00M	$157.00M	$444.00M	$166.00M	$160.00M
Depreciation & amortization	$187.00M	$183.00M	$184.00M	$191.00M	$206.00M	$181.00M	$186.00M	$192.00M	$203.00M	$188.00M	$194.00M	$192.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.